Why Market Dynamics Are Shifting in the China Benign Prostatic Hyperplasia Treatment Market
The China Benign Prostatic Hyperplasia Treatment Market is poised for transformative changes, with projections indicating a market size of approximately 1,346.34 million USD by 2035. This represents a substantial increase from 708.06 million USD, supported by a CAGR of 5.5%. The growing prevalence of benign prostatic hyperplasia among aging males in China is a pivotal factor, creating an urgent...
0 Comments 0 Shares 148 Views 0 Reviews